Suven Life Sciences Limited (NSE:SUVEN)
235.20
+2.95 (1.27%)
Aug 14, 2025, 3:29 PM IST
Suven Life Sciences Statistics
Total Valuation
NSE:SUVEN has a market cap or net worth of INR 51.60 billion. The enterprise value is 51.00 billion.
Market Cap | 51.60B |
Enterprise Value | 51.00B |
Important Dates
The last earnings date was Wednesday, August 13, 2025.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 218.29M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.30% |
Shares Change (QoQ) | +0.34% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 61.38M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 686.53 |
PB Ratio | 46.92 |
P/TBV Ratio | 46.99 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -27.69 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -8,139.72 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -62.80% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 544,674 |
Profits Per Employee | -13.35M |
Employee Count | 138 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +87.89% in the last 52 weeks. The beta is 0.91, so NSE:SUVEN's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | +87.89% |
50-Day Moving Average | 257.12 |
200-Day Moving Average | 167.69 |
Relative Strength Index (RSI) | 35.31 |
Average Volume (20 Days) | 143,622 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUVEN had revenue of INR 75.17 million and -1.84 billion in losses. Loss per share was -8.44.
Revenue | 75.17M |
Gross Profit | 67.65M |
Operating Income | -1.91B |
Pretax Income | -1.84B |
Net Income | -1.84B |
EBITDA | -1.86B |
EBIT | -1.91B |
Loss Per Share | -8.44 |
Balance Sheet
The company has 600.05 million in cash and n/a in debt, giving a net cash position of 600.05 million.
Cash & Cash Equivalents | 600.05M |
Total Debt | n/a |
Net Cash | 600.05M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.10B |
Book Value Per Share | 5.04 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 90.00% |
Operating Margin | -2,544.85% |
Pretax Margin | -2,450.90% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NSE:SUVEN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.30% |
Shareholder Yield | n/a |
Earnings Yield | -3.57% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |